Table 2.
Descriptive statistics by event status of IOP increase (n=30)
| No IOP increase (n=15) | IOP increase (n=15) | No Glaucoma development/progression(n=23) | Glaucoma development/progression (n=7) | |||
|---|---|---|---|---|---|---|
| Continuous Variables | Mean (SD) | Mean (SD) | P-value* | Mean (SD) | Mean (SD) | P-value* |
|
| ||||||
| Number of glaucoma meds, preoperatively | 2.07 (1.4) | 1.13 (1.4) | 0.0780 | 1.61 (1.4) | 1.57 (1.7) | 0.9538 |
| Number of glaucoma meds, postoperatively | 0.73 (1.1) | 1.80 (0.8) | 0.0047 | 1.17 (1.2) | 1.57 (0.8) | 0.4036 |
| Preoperative IOP | 13.67 (5.9) | 18.00 (7.1) | 0.0798 | 14.26 (5.4) | 21.00 (8.7) | 0.0185 |
| Final IOP | 9.50 (3.2) | 12.83 (4.4) | 0.0246 | 10.8 (3.9) | 12.50 (5.0) | 0.3391 |
| Categorical Variables | Frequency (Column %) | Frequency (Column %) | P-value** | Frequency (Column %) | Frequency (Column %) | P-value** |
|
|
||||||
| Glaucoma History | ||||||
| No | 3 (20.0) | 7 (46.7) | 0.2451 | 8 (34.8) | 2 (28.6) | 1.0000 |
| Yes | 12 (80.0) | 8 (53.3) | 15 (65.2) | 5 (71.4) | ||
| Glaucoma Surgery (Preoperative) | ||||||
| No | 8 (53.3) | 14 (93.3) | 0.0352 | 16 (69.6) | 6 (85.7) | 0.6378 |
| Yes | 7 (46.7) | 1 (6.7) | 7 (30.4) | 1 (14.3) | ||
| Concomitant Glaucoma surgery with KPro implant | ||||||
| None | 7 (46.7) | 2 (13.3) | 0.1404 | 7 (30.4) | 2 (28.6) | 0.4985 |
| Ahmed | 2 (13.3) | 4 (26.7) | 6 (26.1) | 0 (0.0) | ||
| Baerveldt | 2 (13.3) | 6 (40.0) | 5 (21.7) | 3 (42.9) | ||
| Endoscopic cyclophotocoagulation | 4 (26.7) | 3 (20.0) | 5 (21.7) | 2 (28.6) | ||
| Glaucoma Surgery (Postoperative) | ||||||
| No | 15 (100.0) | 7 (46.7) | 0.0022 | 21 (91.3) | 1 (14.3) | 0.0003 |
| Yes | 0 (0.0) | 8 (53.3) | 2 (8.7) | 6 (85.71) | ||
*
t-test
**
Fisher’s exact test